Nitric oxide mediates the interleukin-1β- and nicotine induced hypothalamic-pituitary-adrenocortical response during social stress

Journal of Physiology and Pharmacology

Volumn 56, Issue 3, 2005, Pages 491-503

  Gadek Michalska A ^a   Bugajski, J ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

ACTH; Corticosterone; Interleukin 1 ; Nicotine; Nitric oxide; NOS antagonists; Social crowding stress

Indexed keywords

AMINOGUANIDINE; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; INTERLEUKIN 1BETA; N(G) NITROARGININE METHYL ESTER; NICOTINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; VASOPRESSIN ANTAGONIST;

ALPHA HELIX; ANIMAL EXPERIMENT; ANTERIOR HYPOTHALAMUS; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; CYTOKINE PRODUCTION; EVOKED RESPONSE; HORMONAL REGULATION; HORMONE RELEASE; HORMONE RESPONSE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NONHUMAN; RAT; SOCIAL PROBLEM;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; ARGININE VASOPRESSIN; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; CROWDING; ENZYME INHIBITORS; GUANIDINES; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INTERLEUKIN-1; NG-NITROARGININE METHYL ESTER; NICOTINE; NICOTINIC AGONISTS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROARGININE; PITUITARY-ADRENAL SYSTEM; RATS; SOCIAL ENVIRONMENT; STRESS, PSYCHOLOGICAL;

EID: 26044479219     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Buckingham JC, Loxley HD, Christian HC et al. Activation of the HPA axis by immune insult: roles and interactions of cytokines, eicosanoids, and glucocorticoids. Pharmacol Biochem Behav 1996; 54: 285-298.
2. Turnbull AV, Rivier CL. Regulation of the hypothalamo-pituitary adrenal axis by cytokines: actions and mechanisms of action. Physiol Rev 1999; 79: 1-71.
3. John CD, Buckingham JC. Cytokines: regulation of the hypothalamo- pituitary-adrenocortical axis. Current Opinion in Pharmacology 2003; 3: 78-84.
4. Banks WA, Farr SA, Morley JE. Entry of blood-borne cytokines into the central nervous system: effects on cognitive processes. Neuroimmunomodulation 2002; 10: 319-327.
5. Tringali G, Russo C, Preziosi P et al. Interleukin-1 in the central nervous system: from physiology to pathology. Therapie 2000; 55: 171-175.
6. Deak T, Bellamy C, Leah G et al. Exposure to forced swim stress does not alter production of IL-1. Brain Res 2003; 927: 53-63.
7. Deak T, Bordner KA, McElderry NK et al. Stress-induced increases in hypothalamic IL-1: a systematic analysis of multiple stressor paradigms. Brain Res Bull 2005; 64: 541-546.
8. Mormede C, Castanon N, Medina C et al. Chronic mild stress in mice decreases peripheral cytokine and increases central cytokine expression independently of IL-10 regulation of the cytokine network. Neuroimmunomodulation 2002; 10: 359-366.
9. Nguyen KT, Deak T, Will MJ et al. Timecourse and corticosterone sensitivity of the brain, pituitary, and serum interleukin-1β protein response to acute stress. Brain Res 2000; 859: 193-201.
10. Okuda H, Shioda S, Nakai Y et al. The presence of corticotropin-releasing factor-like immunoreactive synaptic vesicles in axon terminals with nicotinic acetylcholine receptor-like immunoreactivity in the median eminence of the rat. Neuroscience Letters 1993; 161: 183-186.
11. Ohmori N, Itoi K, Tozawa F et al. Effect of acetylcholine on corticotropin-releasing factor gene expression in the hypothalamic paraventricular nucleus of conscious rats. Endocrinology 1995; 136: 4858-4863.
12. Matta SG, Fu Y, Valentine JD, Sharp BM. Response of the hypothalamo-pituitary-adrenal axis to nicotine. Psychoneuroendocrinology 1998; 23: 103-113.
13. Dani JA. Overview of nicotinic receptors and their roles in the central nervous system. Biol Psychiatry 2001; 49: 166-174.
14. Stern JE. Nitric oxide and homeostatic control: an intercellular signalling molecule contributing to autonomic and neuroendocrine integration? Prog Biophys Mol Biol 2004; 84: 197-215.
15. Bredt DS. Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Rad Res 1999; 31: 577-596.
16. Kiss JP. Role of nitric oxide in the regulation of monoaminergic neurotransmission. Brain Res Bull 2000; 52: 459-466.
17. Bugajski J, Ga̧dek-Michalska A, Bugajski A. Nitric oxide and prostaglandin systems in the stimulation of hypothalamic-pituitary-adrenal axis by neurotransmitters and neurohormones. J Physiol Pharmacol 2004; 55: 679-703.
18. Ga̧dek-Michalska A, Bugajski J. Role of nitric oxide in the nicotine-induced pituitary-adrenocortical response. J Physiol Pharmacol 2004; 55: 443-455.
19. De Oliveira RMW, Del Bel EA, Mamede-Rosa MLN et al. Expression of neuronal nitric oxide synthase mRNA in stress-related brain areas after restraint in rats. Neurosci Lett 2000; 289: 123-126.
20. Mitsushima D, Masuda J, Kimura F. Sex differences in the stress-induced release of acetylcholine in the hippocampus and corticosterone from the adrenal cortex in rats. Neuroendocrinology 2003; 78: 234-240.
21. Weruaga E, Balkan B, Koylu EO et al. Effects of chronic nicotine administration on nitric oxide synthase expression and activity in rat brain. J Neurosci Res 2002; 67: 689-697.
22. Ga̧dek-Michalska A, Bugajski J. Repeated handling restraint, or chronic crowding impair the hypothalamic-pituitary-adrenocortical response to acute restraint stress. J Physiol Pharmacol 2003; 54: 449-459.
23. Schmidt ED, Aguilera G, Binnekade R et al. Single administration of interleukin-1 increased corticotropin releasing hormone and corticotropin releasing hormone-receptor mRNA in the hypothalamic paraventricular nucleus which paralleled long-lasting (weeks) sensitization to emotional stressors. Neuroscience 2003; 116: 275-283.
24. Schmidt ED, Janszen AW, Wouterlood FG et al. Interleukin-1-induced long-lasting changes in hypothalamic corticotropin-releasing hormone (CRH)-neurons and hyperresponsiveness of the hypothalamus-pituitary-adrenal axis. J Neurosci 1995; 15: 7417-7426.
25. Kim CK, Rivier CL. Nitric oxide and carbon monoxide have a stimulatory role in the hypothalamic-pituitary-adrenal response to physico-emotional stressors in rats. Endocrinology 2000; 141: 2244-2253.
26. Brunetti L, Preziosi P, Ragazzoni E et al. Involvement of nitric oxide in basal and interleukin-1β-induced CRH and ACTH release in vitro. Life Sci 1993; 53: 219-222.
27. Aguilera G, Rabadan-Diehl C. Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation. Regul Pept 2000; 96: 32-29.
28. Bugajski J, Ga̧dek-Michalska A, Borycz J et al. Social stress inhibits the nitric oxide effect on the corticotropin-releasing hormone but not vasopressin-induced pituitary-adrenocortical responsiveness. Brain Res 1999; 817: 220-225.
29. Bugajski J, Ga̧dek-Michalska A, Bugajski AJ. Effect of cyclooxygenase inhibitors on the CRH-induced pituitary-adrenocortical activity during crowding stress. J Physiol Pharmacol 2003; 54: 99-108.
30. Bugajski J, Ga̧dek-Michalska A. Effect of cyclooxygenase inhibitors on the vasopressin induced ACTH and corticosterone response during crowding stress. J Physiol Pharmacol 2003; 54: 247-256.
31. Stalke J, Hader O, Bahr V et al. The role of vasopressin in the nicotine-induced stimulation of ACTH and cortisol in men. Clin Investig 1992; 70: 218-223.
32. Tonnessen BH, Severson SR, Hurt RD et al. Modulation of nitric-oxide synthase by nicotine. J Pharmacol Exp Ther 2000; 295: 601-606.